META vs. RMD
META (Meta Platforms, Inc.) and RMD (ResMed Inc.) are both stocks. META operates in Internet Content & Information (Communication Services), while RMD operates in Medical Instruments & Supplies (Healthcare). Over the past 10 years, META returned 17.60%/yr vs 13.71%/yr for RMD. At a 0.31 correlation, their price movements are largely independent.
Performance
META vs. RMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, META achieves a -11.24% return, which is significantly higher than RMD's -19.39% return. Over the past 10 years, META has outperformed RMD with an annualized return of 17.60%, while RMD has yielded a comparatively lower 13.71% annualized return.
META
- 1D
- -1.28%
- 1M
- -3.98%
- YTD
- -11.24%
- 6M
- -12.06%
- 1Y
- -15.84%
- 3Y*
- 30.58%
- 5Y*
- 12.31%
- 10Y*
- 17.60%
RMD
- 1D
- -1.48%
- 1M
- -6.31%
- YTD
- -19.39%
- 6M
- -22.35%
- 1Y
- -22.67%
- 3Y*
- -2.34%
- 5Y*
- -0.97%
- 10Y*
- 13.71%
META vs. RMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
META Meta Platforms, Inc. | -11.24% | 13.09% | 66.05% | 194.13% | -64.22% | 23.13% | 33.09% | 56.57% | -25.71% | 53.38% |
RMD ResMed Inc. | -19.39% | 6.26% | 34.18% | -16.55% | -19.47% | 23.41% | 38.33% | 37.85% | 36.38% | 39.06% |
Correlation
The correlation between META and RMD is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since May 18, 2012 | 0.31 |
The correlation between META and RMD shifts across timeframes, from 0.19 (1 year) to 0.35 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
META:
$27.47
RMD:
$13.78
META:
21.31
RMD:
14.02
META:
0.88
RMD:
0.43
META:
7.00
RMD:
3.85
META:
$214.96B
RMD:
$5.54B
META:
$176.14B
RMD:
$3.42B
META:
$106.31B
RMD:
$2.10B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
META vs. RMD — Risk / Return Rank
META
RMD
META vs. RMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Meta Platforms, Inc. (META) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| META | RMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.50 | ||
| Sortino ratioReturn per unit of downside risk | +0.80 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 0.85 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | -0.48 | -0.61 | +0.13 |
| Martin ratioReturn relative to average drawdown | -1.01 | -1.42 | +0.41 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| META | RMD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.45 | -0.95 | +0.50 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | -0.03 | +0.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.46 | 0.44 | +0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.54 | 0.52 | +0.03 |
Drawdowns
META vs. RMD - Drawdown Comparison
The maximum META drawdown since its inception was -76.74%, which is greater than RMD's maximum drawdown of -61.61%. Use the drawdown chart below to compare losses from any high point for META and RMD.
Loading charts...
Drawdown Indicators
| META | RMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.74% | -61.61% | -15.13% |
Max Drawdown (1Y)Largest decline over 1 year | -33.30% | -37.28% | +3.98% |
Max Drawdown (3Y)Largest decline over 3 years | -34.15% | -40.09% | +5.94% |
Max Drawdown (5Y)Largest decline over 5 years | -76.74% | -53.99% | -22.75% |
Max Drawdown (10Y)Largest decline over 10 years | -76.74% | -53.99% | -22.75% |
Current DrawdownCurrent decline from peak | -25.73% | -33.74% | +8.01% |
Average DrawdownAverage peak-to-trough decline | -15.26% | -15.98% | +0.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.69% | 15.95% | -0.26% |
Volatility
META vs. RMD - Volatility Comparison
Meta Platforms, Inc. (META) and ResMed Inc. (RMD) have volatilities of 10.48% and 10.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| META | RMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.48% | 10.44% | +0.04% |
Volatility (6M)Calculated over the trailing 6-month period | 26.95% | 19.50% | +7.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.56% | 23.97% | +11.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.05% | 31.12% | +12.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.69% | 31.55% | +7.14% |
Dividends
META vs. RMD - Dividend Comparison
META's dividend yield for the trailing twelve months is around 0.36%, less than RMD's 1.24% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
META Meta Platforms, Inc. | 0.36% | 0.32% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RMD ResMed Inc. | 1.24% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Financials
META vs. RMD - Financials Comparison
This section allows you to compare key financial metrics between Meta Platforms, Inc. and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
META vs. RMD - Profitability Comparison
META - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a gross profit of 46.09B and revenue of 56.31B. Therefore, the gross margin over that period was 81.9%.
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.
META - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported an operating income of 22.87B and revenue of 56.31B, resulting in an operating margin of 40.6%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.
META - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a net income of 26.77B and revenue of 56.31B, resulting in a net margin of 47.5%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.
Frequently Asked Questions
META and RMD have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
META has higher volatility (10.48%) compared to RMD (10.44%). In terms of maximum drawdown, META dropped -76.74% vs RMD's -61.61%.
META currently has the higher Sharpe Ratio (-0.45 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for META and RMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer